Cargando…
Circular RNAs as Potential Theranostics in the Cardiovascular System
Cardiovascular diseases (CVDs) represent the largest contributor to mortality worldwide. Identification of novel therapeutic targets and biomarkers for CVDs is urgently needed. Circular RNAs (circRNAs) are endogenous, abundant, and stable non-coding RNAs formed by back-splicing events. Their role as...
Autores principales: | Bei, Yihua, Yang, Tingting, Wang, Lijun, Holvoet, Paul, Das, Saumya, Sluijter, Joost P.G., Monteiro, Marta Chagas, Liu, Yang, Zhou, Qiulian, Xiao, Junjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205062/ https://www.ncbi.nlm.nih.gov/pubmed/30368217 http://dx.doi.org/10.1016/j.omtn.2018.09.022 |
Ejemplares similares
-
Extracellular Vesicles in Cardiovascular Theranostics
por: Bei, Yihua, et al.
Publicado: (2017) -
Circular RNAs in Cardiovascular Diseases: Regulation and Therapeutic Applications
por: Wang, Lijun, et al.
Publicado: (2023) -
miR-31a-5p promotes postnatal cardiomyocyte proliferation by targeting RhoBTB1
por: Xiao, Junjie, et al.
Publicado: (2017) -
Circular RNAs Sparkle in the Diagnosis and Theranostics of Hepatocellular Carcinoma
por: Wang, Menglan, et al.
Publicado: (2021) -
Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury
por: Bei, Yihua, et al.
Publicado: (2019)